デフォルト表紙
市場調査レポート
商品コード
1663823

不妊治療サービスの市場規模、シェア、成長分析:タイプ別、手順別、サービス別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Fertility Services Market Size, Share, and Growth Analysis, By Type, By Procedure (In Vitro Fertilization with Intracytoplasmic Sperm Injection, Intrauterine Insemination ), By Service, By End-User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 196 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
不妊治療サービスの市場規模、シェア、成長分析:タイプ別、手順別、サービス別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年02月22日
発行: SkyQuest
ページ情報: 英文 196 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

不妊治療サービス市場規模は2023年に438億4,000万米ドルとなり、2024年の477億4,000万米ドルから2032年には944億3,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは8.9%で成長する見通しです。

結婚の遅れ、避妊の選択肢の充実、キャリアアップ重視などの要因によって、母になるのが遅れるという社会的なシフトが、不妊治療サービスの需要を顕著に高めています。国連の報告によると、フランスのような国々では、初産婦の平均年齢が20代後半から30代前半になっています。この変化は不妊率の上昇と相関しており、多くの女性が妊娠の課題に対する有効な解決策として生殖補助医療(ART)を求めるようになっています。妊娠の延期によって自然妊娠の可能性が狭まっているため、家族計画を容易にするためにARTを利用するカップルが増えています。このような状況の変化は、不妊治療の必要性が高まっていることを明確に示しており、市場情勢は大きく拡大するものと思われます。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • ケーススタディ
  • 規制情勢

不妊治療サービス市場規模:タイプ別& CAGR(2025-2032)

  • 市場概要
  • 診断
  • 治療
  • 保存

不妊治療サービス市場規模:手順別& CAGR(2025-2032)

  • 市場概要
  • 卵細胞質内精子注入法(ICSI)による体外受精(IVF)
  • 子宮内人工授精(IUI)
  • ICSIなしの体外受精
  • 代理出産
  • その他の手続き

不妊治療サービス市場規模:サービス別& CAGR(2025-2032)

  • 市場概要
  • 新規非ドナー
  • 凍結非ドナー
  • 卵子・胚バンキング
  • 新規ドナー
  • 凍結ドナー

不妊治療サービス市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 不妊治療クリニック
  • 病院
  • 外科センター
  • 臨床調査機関

不妊治療サービス市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Merck KGaA(Germany)
  • Vitrolife AB(Sweden)
  • Monash IVF Group(Australia)
  • Genea Limited(Australia)
  • Progyny, Inc.(United States)
  • Ferring Pharmaceuticals(Switzerland)
  • CooperSurgical, Inc.(United States)
  • Cook Medical Inc.(United States)
  • The Cooper Companies, Inc.(United States)
  • Virtus Health(Australia)
  • Cryos International(Denmark)
  • Carolinas Fertility Institute(United States)
  • Apollo Fertility(India)
  • Bloom IVF Centre(India)
  • Bangkok IVF Center(Thailand)
  • Medicover Fertility(Sweden)

結論と提言

目次
Product Code: SQMIG35D2292

Fertility Services Market size was valued at USD 43.84 billion in 2023 and is poised to grow from USD 47.74 billion in 2024 to USD 94.43 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The societal shift towards delayed motherhood, driven by factors such as delayed marriages, enhanced birth control options, and a focus on career advancement, has notably increased the demand for fertility services. The United Nations reports a trend in countries like France where the average age of first-time mothers is now in their late twenties to early thirties. This shift correlates with rising infertility rates, prompting many women to seek Assisted Reproductive Technology (ART) as a viable solution to conception challenges. As the biological window for natural conception narrows due to postponed pregnancies, couples are increasingly turning to ART to facilitate family planning. This evolving landscape underscores the growing necessity for fertility treatments, positioning the fertility services market for significant expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fertility Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fertility Services Market Segments Analysis

Global Fertility Services Market is segmented by Type, Procedure, Service, End-User and region. Based on Type, the market is segmented into Diagnosis, Treatment and Preservation. Based on Procedure, the market is segmented into In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), IVF without ICSI, Surrogacy and Other Procedures. Based on Service, the market is segmented into Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor. Based on End-User, the market is segmented into Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fertility Services Market

The growth of the fertility services market is primarily driven by rising infertility rates, which are often attributed to factors such as stress, the decision to delay parenthood, and various lifestyle changes. Furthermore, issues like obesity, smoking, and exposure to environmental pollutants exacerbate the challenges encountered by individuals experiencing reproductive health difficulties. As the demand for effective solutions increases, advancements in assisted reproductive technology (ART) have significantly enhanced treatment options, reflecting the ongoing response to these evolving challenges in fertility management. Overall, these interconnected factors are fueling the expansion of the fertility services sector.

Restraints in the Fertility Services Market

The fertility services market faces significant constraints due to a variety of moral and legal issues associated with reproductive interventions. Practices such as embryo freezing, surrogacy, and egg donation often encounter opposition rooted in religious and cultural beliefs, which can vary widely across different regions. Additionally, the presence of varying legislation in different countries complicates access to these treatments, limiting opportunities for individuals seeking assistance across borders. This legal framework and the associated cultural challenges hinder the widespread acceptance and implementation of assisted reproductive technologies, ultimately impacting the growth and accessibility of fertility services in the market.

Market Trends of the Fertility Services Market

The Fertility Services market is witnessing a notable trend towards the growing adoption of fertility preservation techniques, driven primarily by shifting societal norms and lifestyle choices. As delayed parenthood rises, particularly among millennials, there is a marked increase in demand for services such as egg and sperm freezing. This trend is further fueled by medical conditions necessitating preservation for health reasons. Consequently, innovations in cryopreservation technologies are gaining traction, contributing to the expansion of fertility services globally. This evolving landscape not only reflects changing attitudes towards family planning but also highlights the urgent need for accessible and advanced fertility solutions in today's market.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Fertility Services Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Diagnosis
  • Treatment
  • Preservation

Global Fertility Services Market Size by Procedure & CAGR (2025-2032)

  • Market Overview
  • In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
  • Intrauterine Insemination (IUI)
  • IVF without ICSI
  • Surrogacy
  • Other Procedures

Global Fertility Services Market Size by Service & CAGR (2025-2032)

  • Market Overview
  • Fresh Non-donor
  • Frozen Non-donor
  • Egg & Embryo Banking
  • Fresh Donor
  • Frozen Donor

Global Fertility Services Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

Global Fertility Services Market Size & CAGR (2025-2032)

  • North America (Type, Procedure, Service, End-User)
    • US
    • Canada
  • Europe (Type, Procedure, Service, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Procedure, Service, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Procedure, Service, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Procedure, Service, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monash IVF Group (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Progyny, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ferring Pharmaceuticals (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperSurgical, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Cooper Companies, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virtus Health (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cryos International (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carolinas Fertility Institute (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apollo Fertility (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bloom IVF Centre (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bangkok IVF Center (Thailand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicover Fertility (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations